| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Sierra Oncology, Inc. | 130,798 | 195,000 | 0.09% | ||
| 2 | ADVERUM BIOTECHNOLOGIES INC | 280,000 | 812,000 | 0.39% | ||
| 3 | KALVISTA PHARMACEUTICALS INC | 221,651 | 1,322,000 | 0.63% | ||
| 4 | AEGLEA BIOTHERAPEUTICS INC | 350,133 | 1,523,000 | 0.73% | ||
| 5 | LIPOCINE INC NEW | 420,000 | 1,546,000 | 0.74% | ||
| 6 | OCERA THERAPEUTICS INC | 1,217,872 | 2,558,000 | 1.23% | ||
| 7 | AKARI THERAPEUTICS PLC | 369,490 | 2,601,000 | 1.25% | ||
| 8 | ARCA biopharma Inc | 1,078,932 | 3,075,000 | 1.47% | ||
| 9 | ALCOBRA LTD | 1,537,463 | 3,229,000 | 1.55% | ||
| 10 | STEMLINE THERAPEUTICS INC | 315,980 | 3,381,000 | 1.62% | ||
| 11 | COHERUS BIOSCIENCES INC COM | 129,629 | 3,649,000 | 1.75% | ||
| 12 | HERON THERAPEUTICS INC COM | 405,901 | 5,317,000 | 2.55% | ||
| 13 | Axovant Sciences LTD | 429,590 | 5,336,000 | 2.56% | ||
| 14 | COLUCID PHARMACEUTICALS ORD | 159,110 | 5,792,000 | 2.78% | ||
| 15 | CYTOMX THERAPEUTICS INC COM | 577,831 | 6,350,000 | 3.05% | ||
| 16 | RA PHARMACEUTICALS INC COM | 542,500 | 8,241,000 | 3.95% | ||
| 17 | Audentes Therapeutics, Inc. | 458,882 | 8,246,000 | 3.96% | ||
| 18 | Ascendis Pharma | 721,152 | 14,596,000 | 7.00% | ||
| 19 | DBV Technologies | 373,617 | 18,694,000 | 8.97% | ||
| 20 | EDGE THERAPEUTICS INC | 1,933,582 | 24,170,000 | 11.59% | ||
| 21 | BIOCRYST PHARMACEUTICALS | 6,071,142 | 38,430,000 | 18.43% | ||
| 22 | AVEXIS INC COM | 1,035,657 | 49,432,000 | 23.71% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001786, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
